Horizon Wealth Management LLC Sells 52,923 Shares of iShares Biotechnology ETF $IBB

Horizon Wealth Management LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 96.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,734 shares of the financial services provider’s stock after selling 52,923 shares during the period. Horizon Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $293,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Basepoint Wealth LLC bought a new position in iShares Biotechnology ETF in the fourth quarter worth approximately $26,000. Cary Street Partners Financial LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $29,000. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF in the second quarter worth $25,000. Caitlin John LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter worth $34,000. Finally, Cornerstone Planning Group LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at about $35,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $190.12 on Thursday. iShares Biotechnology ETF has a 1-year low of $127.11 and a 1-year high of $191.15. The business has a 50 day simple moving average of $172.32 and a two-hundred day simple moving average of $171.49.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were given a $0.0238 dividend. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.